ScienceDaily: Health & Medicine News |
- Blood test could transform tuberculosis diagnosis, treatment in developing countries
- Researchers discover new Ebola-fighting antibodies in blood of outbreak survivor
- New drug reverses the effects of blood thinner in patients with brain hemorrhage
- Stroke survivors using mail order pharmacies more likely to take meds
- Bath salts difficult to detect in biological samples, study finds
- Smart skin made of recyclable materials may transform medicine and robotics
- Tying Molecular Knots
- Health insurance status and head and neck cancer diagnoses, outcomes
- Key recurrence detection time for oropharyngeal cancer
- Clot-busting therapy reduces mortality in deadliest form of stroke
- Ebola crisis provides framework for responding to outbreaks like Zika virus
- Stenting and surgery effectively lower long-term risk of stroke
- Different genetic mutation patterns for HPV-positive throat cancer patients based on smoking history
Blood test could transform tuberculosis diagnosis, treatment in developing countries Posted: 19 Feb 2016 03:52 PM PST A simple blood test that can accurately diagnose active tuberculosis could make it easier and cheaper to control a disease that kills 1.5 million people every year. |
Researchers discover new Ebola-fighting antibodies in blood of outbreak survivor Posted: 19 Feb 2016 11:14 AM PST A new group of powerful antibodies to fight Ebola virus has been discovered by a team of scientists. The antibodies, isolated from the blood of a survivor of the 2014 Ebola outbreak and the largest panel reported to date, could guide the development of a vaccine or therapeutic against Ebola. |
New drug reverses the effects of blood thinner in patients with brain hemorrhage Posted: 19 Feb 2016 10:48 AM PST A new treatment can quickly and completely reverse the effects of the blood thinner dabigatran (Pradaxa) in patients suffering a brain bleed. The treatment, idarucizumab (Praxbind), is the first medication on the market designed to neutralize the blood thinner dabigatran. |
Stroke survivors using mail order pharmacies more likely to take meds Posted: 19 Feb 2016 10:48 AM PST Stroke survivors who get medications by mail are more likely to take them as directed than patients who get medications from local pharmacies, according to new research. |
Bath salts difficult to detect in biological samples, study finds Posted: 19 Feb 2016 06:22 AM PST Synthetic cathinones or 'Bath salts' continue to be popular among recreational drug users and a new study highlights the challenges associated with the detection of these drugs in biological evidence. |
Smart skin made of recyclable materials may transform medicine and robotics Posted: 19 Feb 2016 06:21 AM PST Smart skin that can respond to external stimuli could have important applications in medicine and robotics. |
Posted: 18 Feb 2016 05:47 PM PST We all know that tying a knot in our everyday life involves a defined order of crossing ends of the rope. But how do we tie a molecule into a knot? Researchers report rules to define the order of crossing ends of the DNA chain to obtain rapidly self-tying highly knotted nanostructures. |
Health insurance status and head and neck cancer diagnoses, outcomes Posted: 18 Feb 2016 05:02 PM PST Compared to patients with non-Medicaid insurance, uninsured patients and patients with Medicaid are more likely to present with advanced stages of head and neck cancer and have higher overall and cancer-specific mortality rates, according to new research. |
Key recurrence detection time for oropharyngeal cancer Posted: 18 Feb 2016 05:02 PM PST For patients treated with definitive radiation therapy (RT) for oropharyngeal cancer caused by human papillomavirus (HPV), the majority of recurrences can be detected by post-treatment imaging at three months and physical exams during the six months following treatment, according to new research. |
Clot-busting therapy reduces mortality in deadliest form of stroke Posted: 18 Feb 2016 04:59 PM PST The use of clot-busting drugs to clear blood from the brain's ventricles may be the first effective strategy to decrease mortality for a type of catastrophic bleeding stroke, according to phase-3 clinical trial results. The treatment also significantly reduced post-stroke disability in a subset of patients. |
Ebola crisis provides framework for responding to outbreaks like Zika virus Posted: 18 Feb 2016 04:59 PM PST As world leaders grapple with containing the Zika virus, the Ebola epidemic in West Africa provides valuable lessons for how to respond to infectious disease epidemics, according to a new policy report. |
Stenting and surgery effectively lower long-term risk of stroke Posted: 18 Feb 2016 11:51 AM PST Risk of long-term stroke equally and effectively lowered in stenting and invasive surgery procedures. |
Different genetic mutation patterns for HPV-positive throat cancer patients based on smoking history Posted: 18 Feb 2016 10:50 AM PST Preliminary findings from a study examining the genetic alterations in HPV-positive oropharyngeal squamous cell carcinoma were recently presented. Researchers found differences in the genetic mutations of HPV-positive oropharyngeal cancer based on whether patients were heavy versus light smokers. |
You are subscribed to email updates from Health & Medicine News -- ScienceDaily. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google Inc., 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |
ليست هناك تعليقات:
إرسال تعليق